{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T06:08:18Z","timestamp":1761718098974},"reference-count":30,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T00:00:00Z","timestamp":1247011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Birth Defects Research"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>BACKGROUND:<\/jats:bold> Moderate caffeine intake during pregnancy is common, but little is known about its potential association with birth defects. <jats:bold>METHODS:<\/jats:bold> The National Birth Defects Prevention Study is a population\u2010based, case\u2010control study of major birth defects, excluding infants with single\u2010gene disorders and chromosomal abnormalities. This analysis includes infants with cleft lip with or without cleft palate (CL\/P) and cleft palate only (CPO), excluding infants whose cleft was secondary to holoprosencephaly or amniotic band sequence. Mothers reported dietary caffeine intake from coffee, tea, sodas, and chocolate in the year before pregnancy and reported intake of medications containing caffeine during pregnancy. We assessed the association between dietary caffeine intake, frequency of consuming each type of caffeinated beverage, medications containing caffeine, and CL\/P or CPO among infants born from October 1997 through December 2004. <jats:bold>RESULTS:<\/jats:bold> This analysis included 1531 infants with CL\/P, 813 infants with CPO, and 5711 infants with no major birth defects (controls). Examining dietary sources among control mothers, 11% reported consuming at least 300 mg of caffeine per day and 17% reported consuming less than 10 mg of caffeine per day; high consumption (\u22653 servings per day) was reported by 8% (coffee), 4% (tea), and 15% (sodas); medications containing at least 100 mg caffeine\/dose were reported by less than 1%. Although some effect estimates were elevated for moderate caffeine intake from all beverages, estimates were closer to the null for high caffeine levels. Isolated CL\/P was associated with use of medications containing at least 100 mg of caffeine per dose. <jats:bold>CONCLUSIONS:<\/jats:bold> Our data do not suggest an association between maternal dietary caffeine intake and orofacial clefts, but caffeine\u2010containing medications merit further study. Birth Defects Research (Part A), 2009. \u00a9 2009 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/bdra.20600","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T01:34:31Z","timestamp":1247189671000},"page":"842-849","source":"Crossref","is-referenced-by-count":24,"title":["Maternal caffeine intake during pregnancy and orofacial clefts"],"prefix":"10.1002","volume":"85","author":[{"given":"Sarah A.","family":"Collier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn L.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Honein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-006-9099-5"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.c.30004"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000208476.36988.44"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20365"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20294"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2007.05.046"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.028"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.16.3.193"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2004.10.027"},{"key":"e_1_2_6_11_1","article-title":"Orofacial clefts in the National Birth Defects Prevention Study","author":"Genisca AE","year":"1997","journal-title":"Am J Med Genet Part A"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104123441504"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000254430.61294.c0"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyn098"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/134.11.3106"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.73.12.1397"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20096"},{"key":"e_1_2_6_18_1","first-page":"213","article-title":"Tobacco smoking and oral clefts: a meta\u2010analysis","volume":"82","author":"Little J","year":"2004","journal-title":"Bull World Health Organ"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.82.1.91"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/37.3.416"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2005.01477.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197824140"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.10012"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwm146"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jama.1982.03320350033024","article-title":"Selected birth defects in relation to caffeine\u2010containing beverages","volume":"247","author":"Rosenberg L","year":"1982","journal-title":"J Am Med Assoc"},{"key":"e_1_2_6_26_1","first-page":"9","article-title":"Craniofacial and limb development in early rat embryos following in utero exposure to ethanol and caffeine","volume":"170","author":"Ross CP","year":"1990","journal-title":"Anat Anz"},{"key":"e_1_2_6_27_1","volume-title":"Modern epidemiology","author":"Rothman KJ","year":"2008"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90157-9"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2008.08.006"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.32897"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/phr\/116.S1.32"}],"container-title":["Birth Defects Research Part A: Clinical and Molecular Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fbdra.20600","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bdra.20600","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T06:26:28Z","timestamp":1697437588000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bdra.20600"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,8]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1002\/bdra.20600"],"URL":"https:\/\/doi.org\/10.1002\/bdra.20600","archive":["Portico"],"relation":{},"ISSN":["1542-0752","1542-0760"],"issn-type":[{"value":"1542-0752","type":"print"},{"value":"1542-0760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,8]]}}}